Osborn Williams & Donohoe LLC reduced its stake in Cardinal Health, Inc. (NYSE:CAH) by 11.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 22,025 shares of the company’s stock after selling 2,857 shares during the quarter. Osborn Williams & Donohoe LLC’s holdings in Cardinal Health were worth $1,474,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Bronfman E.L. Rothschild L.P. lifted its holdings in Cardinal Health by 31.8% in the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock worth $123,000 after purchasing an additional 382 shares during the last quarter. Advisory Services Network LLC lifted its holdings in Cardinal Health by 18.4% in the 2nd quarter. Advisory Services Network LLC now owns 1,739 shares of the company’s stock worth $136,000 after purchasing an additional 270 shares during the last quarter. JFS Wealth Advisors LLC lifted its holdings in Cardinal Health by 14.3% in the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after purchasing an additional 244 shares during the last quarter. Dupont Capital Management Corp acquired a new stake in Cardinal Health in the 2nd quarter worth approximately $164,000. Finally, First Personal Financial Services lifted its holdings in Cardinal Health by 127.5% in the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after purchasing an additional 1,238 shares during the last quarter. Hedge funds and other institutional investors own 87.88% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://stocknewstimes.com/2017/10/18/osborn-williams-donohoe-llc-has-1-47-million-position-in-cardinal-health-inc-cah.html.
Shares of Cardinal Health, Inc. (CAH) traded up 1.11% on Wednesday, hitting $65.80. The stock had a trading volume of 562,098 shares. The company has a market cap of $20.82 billion, a PE ratio of 16.33 and a beta of 0.86. Cardinal Health, Inc. has a 52 week low of $62.70 and a 52 week high of $84.88. The stock’s 50-day moving average price is $67.26 and its 200 day moving average price is $72.72.
Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.24 by $0.07. The business had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm posted $1.14 EPS. On average, analysts predict that Cardinal Health, Inc. will post $4.95 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Sunday, October 15th. Investors of record on Monday, October 2nd were issued a dividend of $0.4624 per share. The ex-dividend date was Friday, September 29th. This represents a $1.85 annualized dividend and a yield of 2.84%. Cardinal Health’s payout ratio is currently 45.79%.
Several equities research analysts recently weighed in on the company. UBS AG restated a “neutral” rating and issued a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Credit Suisse Group restated an “outperform” rating and issued a $87.00 target price (up from $81.00) on shares of Cardinal Health in a report on Thursday, July 13th. BidaskClub lowered Cardinal Health from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Zacks Investment Research lowered Cardinal Health from a “hold” rating to a “sell” rating in a report on Monday, August 7th. Finally, Cowen and Company restated a “market perform” rating and issued a $77.00 target price (down from $82.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $76.54.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.